Ketan K. Badani, MD, Professor of Urology, Icahn School of Medicine at Mount Sinai in New York, has been named Vice Chairman of Urology and Robotic Operations and Director of the Comprehensive Kidney Cancer Program for the Mount Sinai Health System. Dr. Badani will also serve as Director of Robotic Surgery at Mount Sinai, St. Luke’s, and Mount Sinai Roosevelt.
“Dr. Badani brings an innovative approach to treatment of kidney disease,” said Ash Tewari MBBS, MCh, Kyung Hyun Kim, MD, Chair in Urology, Icahn School of Medicine at Mount Sinai and Chairman, Milton and Carroll Petrie Department of Urology at The Mount Sinai Hospital. “He is one of the most talented physicians in urology and we are fortunate to have him join our team.”
Dr. Badani has extensive experience in robotic kidney and prostate cancer surgery. He has performed nearly 4,000 robotic procedures. Dr. Badani developed the breakthrough surgical technique known as FAST Robotic Partial Nephrectomy, which removes the cancerous portion of the kidney tiny openings, and leaves the normal, functional kidney tissue in the body. He also led one of the largest studies evaluating genomic biomarkers for the active surveillance or close monitoring of men with low-risk prostate cancer.
In joining Mount Sinai, Dr. Badani said, “My goal is to grow our comprehensive kidney program into the world-class center spanning the treatment spectrum including surgery, ablation, surveillance, nephology, interventional radiology, and complementary medicine.”
Dr. Badani comes to Mount Sinai from New York Presbyterian Hospital/Columbia University in New York, where he was Director of Robotic and Minimally Invasive Surgery.
Mount Sinai also welcomes Reza Mehrazin, MD, John Sfakianos, MD, and Seema Sheth, MD, as Assistant Professors of Urology, Icahn School of Medicine at Mount Sinai.
Dr. Mehrazin has extensive training and certification in minimally invasive organ preservation and reconstructive techniques for patients with kidney and bladder cancer. His expertise includes open, laparoscopic, and robotic surgical techniques for the treatment of various urologic cancers.
Dr. Sfakianos is a fellowship-trained urologic oncologist with clinical expertise in bladder and upper urinary tract urothelial carcinoma. An expert in advanced and complicated urological cancers, Dr. Sfakianos is skilled in both open and robotic procedures in the management of kidney, prostate, testicular and penile cancers.
Dr. Sheth’s clinical interest include benign to malignant disorders affecting the urologic tract. ■